Deerfield
About Deerfield

Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.

Read More
---
Investment

Supporting companies across the healthcare ecosystem with flexible funding models…

Read More
---
Information

Delivering market research to the Deerfield team, its portfolio companies and other partners.

Read More ---
Philanthropy

A New York City-based not-for-profit devoted to advancing innovative health care initiatives.

Read More
---
Portfolio Companies

Deerfield generally maintains a combined portfolio of more than 150 private and public investments across the life science, medical device, diagnostic, digital health and health service industries at all stages of evolution from start-up to mature company.

Read More View Portfolio Companies
---
Research Collaborations

Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.

Read More View Research Collaborations
---
Strategic Partners

As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and unique access to innovation.

Read More
---
Deerfield Foundation

The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.

Read More Meet the Foundation Team
---
Cure Campus

Cure is a 12-story innovation campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.

Read More Join the Cure Email List
Cure Programming

Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.

Events at the Cure

Steven Hochberg

Steven Hochberg is an Operating Partner on the Medical Technologies team and joined the Firm in 2013 to work on structured transactions in Deerfield’s Private Design Funds. He has been a founder and manager of healthcare companies for more than twenty years. In addition to his role with Deerfield, since 2004, Mr. Hochberg has managed Ascent Biomedical Ventures, a venture capital firm he co-founded focused on early stage investment and development of biomedical companies. In 2022, he co-founded Triatomic Capital, a technology-focused venture capital firm. Since 2011, Mr. Hochberg has been the Chairman of the Board of Continuum Health Partners until its merger with Mount Sinai in 2013, where he is now the Vice Chairman of the Mount Sinai Health System, a non-profit healthcare integrated delivery system in New York City with over $8 billion in annual revenues. He graduated from the University of Michigan with a B.S. in Business Administration and earned his M.B.A. from Harvard Business School.